SavedAdd your journal

Journals / Anadolu Kardiyoloji Dergisi / 2009 / Cilt: 9 - Sayı: 4

Drug-eluting stents in multivessel coronary artery disease: Was one of the important fortresses of surgery conquered?

Çok damar koroner arter hastalığında ilaç salınımlı stentler: Cerrahinin önemli kalelerinden biri fethedildi mi?

Arda Şanlı ÖKMEN
Ertan ÖKMEN
Pages
325–330
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The aim of this review is to discuss the efficacy and safety of drug eluting stents in patients with multivessel disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Since the drug eluting stents have provided better results concerning restenosis and repeat revascularization comparing to bare metal stents, percutaneous coronary interventions are performing increasingly in more complex stenoses.
📊
Key Findings & Data:However, drug eluting stents did not show any advantage on prevention of myocardial infarction and survival.
💡
Conclusion & Impact:The aim of this review is to discuss the efficacy and safety of drug eluting stents in patients with multivessel disease.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Since the drug eluting stents have provided better results concerning restenosis and repeat revascularization comparing to bare metal stents, percutaneous coronary interventions are performing increasingly in more complex stenoses. However, drug eluting stents did not show any advantage on prevention of myocardial infarction and survival. Currently there is no any completed controlled randomized study showing the superiority or equality of drug eluting stents over coronary bypass surgery by means of efficacy and safety. While the long-term results of drug eluting stents still unclear, everyday progressively more patients with multivessel disease are undergoing percutaneous coronary intervention with drug eluting stent implantation. The aim of this review is to discuss the efficacy and safety of drug eluting stents in patients with multivessel disease.

Özet

İlaç salınımlı stentlerin, çıplak metal stentlerle karşılaştırıldığında, restenoz ve tekrar revaskülarizasyon açısından daha iyi sonuçlar sağlamasıyla perkütan koroner girişimler giderek artan oranlarda daha kompleks darlıklara uygulanmaktadır. Bununla birlikte ilaç salınımlı stentler, sağkalımda ve miyokard infarktüsünü önlemede avantaj sağlamamıştır. Henüz çok damar hastalarında ilaç salınımlı stentlerin koroner baypastan üstün ya da eşdeğer etkinlik ve güvenlikte olduğunu gösteren sonlanmış randomize kontrollü çalışma yoktur. İlaç salınımlı stentlerin uzun dönem sonuçları ile ilgili bilgiler de net değilken, her gün giderek artan sayıda çok damar hastasına ilaç salınımlı stent ile perkütan koroner girişim uygulanmaktadır. Bu derlemede ilaç salınımlı stentlerin çok damar hastalarında etkinlik ve güvenliklerinin tartışılması amaçlanmıştır.

🔖

Cite This Article

ÖKMEN, A. Ş., ÖKMEN, E. (2022). Drug-eluting stents in multivessel coronary artery disease: Was one of the important fortresses of surgery conquered?. Anadolu Kardiyoloji Dergisi, Cilt: 9 - Sayı: 4, 325–330. https://ajindex.com/articles/436919

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Ökmen E, Kaşıkçıoğlu H, Şanlı A, Uyarel H, Tartan Z, Cam N. Correlations between cardiac troponin I cardiac troponin T and creatine phosphokinase MB elevation following successful percutaneous coronary intervention and prognostic value of each marker. J Invasive Cardiol 2005; 17: 63-7
  2. Ökmen E, Şanlı A, Kaşıkçıoğlu H, Dayı S, Çam N. Effects of glycoprotein IIb/IIIa inhibition with tirofiban on minor myocardial injury in successful coronary angioplasty. Cardiology 2004; 102; 18-23
  3. Ökmen E. Endotel ve koroner girişimler. In: Şan M, Editör. Yaşamın Gizli Gücü: Endotel ve Sistemlerimiz. İstanbul: Printaş Basım AŞ; 2005. p. 201-26
  4. Ökmen E, Kaşıkçıoğlu H, Uyarel H, Erdem I, Vural M. The effects of direct stent implantation and conventional stent implantation on minor myocardial injury in percutaneous coronary intervention. J Am Coll Cardiol 2002; 39: 320B
  5. Ökmen E, Şanlı A, Tartan Z, Uyarel H, Kaşıkçıoğlu H, Çam N. Long-term follow-up after angiographically successful coronary stenting: Direct stent versus conventional stent implantation. Jpn Heart J 2004; 45: 53-61
  6. Ökmen E, N Cam. Direct stent implantation: Feasibility advantages and disadvantages. Anadolu Kardiyol Derg 2002; 3: 237-43
  7. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996; 335: 217-25
  8. RITA Trial participants. Coronary angioplasty versus coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial. Lancet 1993; 341: 573-80
  9. King SB 3rd, Lembo NJ, Weintraub WS, Kosinski AS, Barnhart HX, Kutner MH, et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery: Emory Angioplasty versus Surgery Trial (EAST). N Engl J Med 1994; 331: 1044-50
  10. Smith PK, Califf RM, Tuttle RH, Shaw LK, Lee KL, Delong ER, et al. Selection of surgical or percutaneous coronary intervention provides differential longevity benefit. Ann Thorac Surg 2006; 82: 1420-9
  11. Brener SJ, Lytle BW, Casserly IP, Schneider JP, Topol EJ, Lauer MS. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation 2004; 109: 2290-5
  12. Hannan EL, Racz MJ, Walford G, Jones RH, Ryan TJ, Bennett E, et al. Long-term outcomes of coronary artery by-pass grafting versus stent implantation. N Engl J Med 2005; 352